InsidersTradesSigma
Discover the full record of transactions filed by Levine Mitchell S, Chief Financial Officer. Director active across 1 companies, notably OncoCyte Corp. Aggregated, 1 disclosures have been recorded. Total volume traded: €27k. The latest transaction was disclosed on 15 March 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Levine Mitchell S is the Chief Financial Officer of OncoCyte Corp. He is responsible for the company's financial management, including budgeting and performance analysis. His role is essential to ensure the financial health of the organization.